Wednesday, February 10, 2010, 2:35pm SGT - The Singapore stock market closes in 2 hours and 25 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Teva Pharmaceutical Industries Limited (TEVA)

At 5:00AM SGT: 57.10 USD  Up 0.18 (0.32%)  
 MORE ON TEVA 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Teva Pharmaceutical Industries (NasdaqNM:TEVA) Delayed quote dataEdit
After Hours: 57.48 Up 0.38 (0.67%) as of 6:21am SGT on 02/10/10
Last Trade:57.10 USD
Trade Time:5:00AM SGT
Change:Up 0.18 (0.32%)
Prev Close:56.92
Open:57.31
Bid:56.14 x 100
Ask:57.97 x 100
1y Target Est:65.25
Day's Range:56.72 - 57.59
52wk Range:42.00 - 59.62
Volume:4,539,807
Avg Vol (3m):4,959,040
Market Cap:50.31B
P/E (ttm):52.24
EPS (ttm):1.09
Div & Yield:0.61 (1.06%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add TEVA to Portfolio   Download Data

 HEADLINES 
[video] Stock Wrap: The Real Story, February 9
at TheStreet.com (Wed 5:52am)
AstraZeneca Goes to the Well One Last Time
at Minyanville.com (Wed 1:50am)
The New Danger for Foreign Investors?
at Motley Fool (Wed 12:22am)
Five Growth Stocks With a Margin of Safety
at TheStreet.com (Tue 6:00pm)
Teva gets Nordic and Baltic rights for MS drug from Active Biotech
at bizjournals.com (Tue 1:05am)
Teva, Active extend pact on oral MS therapy
at MarketWatch (Mon, Feb 8)
Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
Business Wire (Mon, Feb 8)
Teva Settles Lawsuits for $315 Million
at Fox Business (Sat, Feb 6)
[$$] Teva Reaches Preliminary Settlement In Drug Pricing Suit
at The Wall Street Journal Online (Sat, Feb 6)
Emerging-Market ETFs Still Have Steam
at TheStreet.com (Sat, Feb 6)
More Headlines for TEVA...

 ANALYST 
EPS Est (next year) (Dec-09) :3.37
EPS Est (in 2 years) (Dec-10) :4.52
Avg Rec (current)*:1.6
PEG Ratio:1.15
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Teva Pharmaceutical Industries Limited engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices